Charles Schwab Investment Management Inc Immunity Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,775,566 shares of IBRX stock, worth $4.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,775,566

Previous 1,302,083 36.36%

Holding current value

$4.35 Million

Previous $3.92 Million 19.6%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.89 - $3.44 $894,882 - $1.63 Million	473,483 Added 36.36%	1,775,566 $4.69 Million
Q1 2025 Sep 15, 2025	SELL	$2.32 - $3.9 $1.1 Million - $1.85 Million	-473,483 Reduced 26.67%	1,302,083 $3.92 Million
Q1 2025 May 09, 2025	BUY	$2.32 - $3.9 $58,951 - $99,099	25,410 Added 1.99%	1,302,083 $3.92 Million
Q4 2024 Feb 06, 2025	BUY	$2.56 - $6.17 $27,371 - $65,969	10,692 Added 0.84%	1,276,673 $3.27 Million
Q3 2024 Nov 12, 2024	BUY	$3.32 - $6.7 $98,487 - $198,755	29,665 Added 2.4%	1,265,981 $4.7 Million
Q2 2024 Aug 12, 2024	BUY	$4.82 - $9.15 $313,801 - $595,701	65,104 Added 5.56%	1,236,316 $7.81 Million
Q1 2024 May 08, 2024	BUY	$3.23 - $6.17 $91,367 - $174,530	28,287 Added 2.47%	1,171,212 $6.29 Million
Q4 2023 Feb 06, 2024	BUY	$1.25 - $5.21 $116,238 - $484,483	92,991 Added 8.86%	1,142,925 $5.74 Million
Q3 2023 Nov 08, 2023	BUY	$1.29 - $3.1 $92,089 - $221,299	71,387 Added 7.3%	1,049,934 $1.77 Million
Q2 2023 Aug 09, 2023	BUY	$1.53 - $6.41 $402,255 - $1.69 Million	262,912 Added 36.74%	978,547 $2.72 Million
Q1 2023 May 11, 2023	SELL	$1.35 - $4.78 $10,643 - $37,685	-7,884 Reduced 1.09%	715,635 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $49,159 - $76,507	11,301 Added 1.59%	723,519 $3.67 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $868,510 - $1.53 Million	237,948 Added 50.17%	712,218 $3.54 Million
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $50,354 - $115,364	-18,789 Reduced 3.81%	474,270 $1.77 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.53 $84,193 - $125,540	16,672 Added 3.5%	493,059 $2.77 Million
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $103,091 - $185,092	18,182 Added 3.97%	476,387 $2.9 Million
Q3 2021 Nov 16, 2021	SELL	$9.17 - $14.24 $308,607 - $479,232	-33,654 Reduced 6.84%	458,205 $4.46 Million
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $3.15 Million - $5.26 Million	234,631 Added 91.22%	491,859 $7.02 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $3.3 Million - $10.9 Million	257,228 New	257,228 $6.11 Million

Others Institutions Holding IBRX

# of Institutions

274

Shares Held

120M

Call Options Held

2.49M

Put Options Held

3.14M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $981M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Immunity Bio, Inc. Transaction History